Advertisement
UK markets closed
  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     
  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     
  • AIM

    755.28
    +2.16 (+0.29%)
     
  • GBP/EUR

    1.1680
    +0.0023 (+0.20%)
     
  • GBP/USD

    1.2495
    -0.0016 (-0.12%)
     
  • Bitcoin GBP

    51,185.28
    -461.65 (-0.89%)
     
  • CMC Crypto 200

    1,330.86
    -65.68 (-4.70%)
     
  • S&P 500

    5,099.96
    +51.54 (+1.02%)
     
  • DOW

    38,239.66
    +153.86 (+0.40%)
     
  • CRUDE OIL

    83.66
    +0.09 (+0.11%)
     
  • GOLD FUTURES

    2,351.40
    +8.90 (+0.38%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,161.01
    +243.73 (+1.36%)
     
  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     

BUZZ-Top of the Street: Equinor, Boliden, Galapagos, Fuchs Petrolub

A round-up of notable broker activity this morning from Europe's top-ranked* analysts:

** Pareto Securities double downgrades Equinor to "sell" from "buy", which should be seen in light of downgrade of oil price forecast for next year

** Polymetal: JP Morgan cuts to "underweight" from "neutral" on valuation grounds and 2019 capex creep

** JP Morgan also raises Boliden (LSE: 0MI5.L - news) to "neutral" from "underweight"

** Credit Suisse (IOB: 0QP5.IL - news) upgrades Galapagos (LSE: 0JXZ.L - news) to "outperform" from "neutral", saying that it sees multiple possible pathways to further upside

** European Insurance: Barclays (LSE: BARC.L - news) raises to "positive" from "neutral", as fundamentals are incrementally improving across all subsectors

ADVERTISEMENT

INITIATIONS AND REINSTATEMENTS

** Credit Suisse starts Fuchs Petrolub (Swiss: FPE3.SW - news) with "underperform", saying co is priced as a defensive stock, which the brokerage views as unwarranted given its more cyclical historical performance and lower 2019E EBITDA margins, FCF yield and dividend yield

(*Analyst rankings from Thomson Reuters StarMine. Scale is from 1-star to 5-star with 5 being best. Analysts ranked on earnings accuracy as well as relative performance of recommendations over trailing 12-month & 24-month periods.) (magdalena.pilarczyk@tr.com; anita.kobylinska@tr.com)